Fucoxanthin
Antioxidant ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Fucoxanthin is a xanthophyll carotenoid found in the chloroplasts of brown seaweeds such as wakame (Undaria pinnatifida), hijiki, and kombu. It is marketed for fat metabolism and metabolic support, with most supporting data coming from animal studies and a limited number of small human trials. After ingestion it is metabolized to fucoxanthinol and amarouciaxanthin A, which are thought to carry most of the biological activity.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Fucoxanthin is an antioxidant most often used for may support fat metabolism and body-composition goals (preliminary evidence), antioxidant activity, possible support for healthy lipid profiles. NutriStack rates the overall evidence as emerging. A typical adult dose is 2.4 to 8 mg per day of fucoxanthin (often delivered as a standardized brown-seaweed extract); commercial trials have used up to about 16 mg combined with pomegranate seed oil, commonly taken as standardized brown-seaweed (undaria pinnatifida) extract softgel or capsule, often formulated with a dietary fat or oil to improve absorption. This profile indexes 9 sources.
- Generally well tolerated in short-term studies
- Possible mild gastrointestinal upset
- Limited long-term safety data in humans
- Pregnancy and breastfeeding (insufficient safety data)
- Thyroid disorders or iodine sensitivity (seaweed-derived products may contain iodine)
The bottom line
Evidence rating emerging. Most-documented uses: may support fat metabolism and body-composition goals (preliminary evidence), antioxidant activity, possible support for healthy lipid profiles. 9 sources indexed (2005–2015), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Fucoxanthin is converted in the gut and liver to its primary metabolites fucoxanthinol and amarouciaxanthin A, which accumulate in adipose tissue. In rodent models it is proposed to upregulate uncoupling protein 1 (UCP1) in white adipose tissue, promoting a more thermogenic, brown-fat-like phenotype and increasing energy expenditure. It may also modulate lipid metabolism by influencing enzymes such as the sterol regulatory pathway and by reducing adipocyte differentiation, and it exhibits antioxidant activity by quenching reactive oxygen species and singlet oxygen owing to its unique allenic bond and conjugated polyene structure. Some preclinical work suggests effects on glucose handling and hepatic lipid accumulation, though the translation of these mechanisms to humans at practical doses is not well established.6,1
Dosing & protocol.
As a fat-soluble carotenoid, fucoxanthin is absorbed better when taken with a meal containing dietary fat. Bioavailability of the parent compound is relatively low; it is largely converted to fucoxanthinol and amarouciaxanthin A.1,5
What it actually costs.
Real-world pricing across three quality tiers. Assumes Standardized brown-seaweed (Undaria) extract softgel.
Pricing reflects products dosed at roughly 2.4 to 5 mg of actual fucoxanthin per day. Cost varies widely with the standardized fucoxanthin percentage, so compare on mg of fucoxanthin rather than total extract or capsule count. Premium tier covers oil-combination (Xanthigen-style) formulas, which run higher. Updated 2026-06-04.
Full safety detail.
Side effects
- Generally well tolerated in short-term studies
- Possible mild gastrointestinal upset
- Limited long-term safety data in humans
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Randomized controlled trials
2- 1The Use of Fucoxanthin in the Treatment of Patients with Non-Alcoholic Fatty Liver Disease, Obesity, and Type 2 Diabetes MellitusAbidov M et al. · Diabetes, Obesity and Metabolism · 2010
Supplementation with Xanthigen (fucoxanthin plus pomegranate seed oil) was associated with reductions in body weight and liver fat and an increase in resting energy expenditure compared with placebo.
- 2The effect of xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fatSource linkedPMIDAbidov M, Ramazanov Z, Seifulla R, Grachev S · Diabetes, Obesity and Metabolism · 2010
Reviews & position papers
2- 3Effect of brown seaweed-derived fucoxanthin on body composition and metabolic markers: a systematic review of human and animal studiesSource linkedPMIDGammone MA, D'Orazio N · Marine Drugs · 2015
- 4Bioactivities of fucoxanthin and its potential clinical applicationsPeng J et al. · Marine Drugs · 2011
Fucoxanthin shows antioxidant, anti-obesity, and anti-diabetic activity primarily in preclinical models, with human clinical evidence still limited.
Observational studies
1- 5Bioavailability and pharmacokinetics of fucoxanthin and its metabolite fucoxanthinol in humans after a single oral doseSource linkedPMIDHashimoto T, Ozaki Y, Mizuno M, Yoshida M, Nishitani Y, Azuma T, Komoto A, Maoka T, Tanino Y, Kanazawa K · British Journal of Nutrition · 2012
Mechanistic & preclinical
4- 6Fucoxanthin, a carotenoid derived from brown seaweeds, and its metabolite fucoxanthinol: bioavailability and metabolismHashimoto T et al. · British Journal of Nutrition · 2009
Orally administered fucoxanthin is converted to fucoxanthinol and amarouciaxanthin A, which are detected in plasma and tissues including adipose tissue.
- 7Anti-obesity and anti-diabetic effects of fucoxanthin on Otsuka Long-Evans Tokushima Fatty (OLETF) ratsSource linkedDOIMaeda H, Hosokawa M, Sashima T, Takahashi N, Kawada T, Miyashita K · Molecular Medicine Reports · 2009
- 8Fucoxanthin attenuates weight gain and adipose tissue inflammation in diet-induced obese miceSource linkedDOIMaeda H, Hosokawa M, Sashima T, Miyashita K · Journal of Agricultural and Food Chemistry · 2007
- 9Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissuesMaeda H et al. · Biochemical and Biophysical Research Communications · 2005
Fucoxanthin induced UCP1 expression in white adipose tissue of mice and rats, supporting a thermogenic mechanism for its anti-obesity effect.
Common questions.
Quick answers about Fucoxanthin, drawn from the data on this page.
What is Fucoxanthin?
Fucoxanthin is a xanthophyll carotenoid found in the chloroplasts of brown seaweeds such as wakame (Undaria pinnatifida), hijiki, and kombu. It is marketed for fat metabolism and metabolic support, with most supporting data coming from animal studies and a limited number of small human trials. After ingestion it is metabolized to fucoxanthinol and amarouciaxanthin A, which are thought to carry most of the biological activity.
What is Fucoxanthin used for?
Commonly cited benefits of Fucoxanthin include: May support fat metabolism and body-composition goals (preliminary evidence); Antioxidant activity; Possible support for healthy lipid profiles; Possible support for glucose metabolism (preliminary). NutriStack rates the overall evidence as emerging.
What is a typical dose of Fucoxanthin?
A typical adult dose of Fucoxanthin is 2.4 to 8 mg per day of fucoxanthin (often delivered as a standardized brown-seaweed extract); commercial trials have used up to about 16 mg combined with pomegranate seed oil. The commonly recommended form is Standardized brown-seaweed (Undaria pinnatifida) extract softgel or capsule, often formulated with a dietary fat or oil to improve absorption. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Fucoxanthin?
Reported side effects include generally well tolerated in short-term studies, possible mild gastrointestinal upset, limited long-term safety data in humans. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Fucoxanthin?
NutriStack rates this as Emerging, meaning early RCT signal, mechanistic data, or limited human evidence. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Fucoxanthin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.